MFC:NYSEManulife Financial Corporation Analysis
Data as of 2026-05-24 - not real-time
$38.53
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Manulife Financial (MFC) is trading at $38.53, just below its 20‑day SMA of $38.92 but comfortably above the 50‑day ($37.11) and 200‑day ($34.75) averages, indicating a still‑bullish medium‑term trend. The RSI sits at 51, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure near the $36.97 support level. Fundamentally, the stock trades at a forward PE of 10.8 versus an industry average of 16.8, and its trailing PE of 15.3 is also below peers, signaling clear valuation headroom. The DCF model projects a fair value of $74.65, implying more than a 90% upside from current levels, though the model’s upside/downside metric shows a modest -10.7% discrepancy that warrants caution. Revenue growth of 12% and a solid 3.49% dividend yield with a 52% payout ratio underline both growth and income appeal. Recent quarterly news highlighted strong insurance sales in Asia offsetting weaker performance in the wealth‑management segment, and the board confirmed a $0.485 per share dividend, reinforcing cash flow resilience.
Liquidity remains healthy with increasing volume, a market cap of $64.3 B, and cash of $30.3 B far exceeding debt of $23.5 B. However, the stock’s 30‑day volatility of 27% and beta near 1.0 point to market‑wide risk, while exposure to multiple regions (North America and Asia) and currencies adds moderate geographic and currency considerations. Overall, the blend of undervalued pricing, sustainable dividend, and growth‑driven earnings supports a positive outlook across horizons.
Liquidity remains healthy with increasing volume, a market cap of $64.3 B, and cash of $30.3 B far exceeding debt of $23.5 B. However, the stock’s 30‑day volatility of 27% and beta near 1.0 point to market‑wide risk, while exposure to multiple regions (North America and Asia) and currencies adds moderate geographic and currency considerations. Overall, the blend of undervalued pricing, sustainable dividend, and growth‑driven earnings supports a positive outlook across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Price near support with bullish SMA alignment
- Attractive dividend yield and payout ratio
- Technical bearish MACD providing entry discount
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth driven by Asian insurance sales
- Valuation gap versus peers (low forward PE)
- Sustained dividend and strong cash position
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term cash generation and low debt‑to‑equity ratio
- DCF implied upside and consistent earnings profile
- Diversified geographic footprint reducing single‑market exposure
Key Metrics & Analysis
Financial Health
Revenue Growth12.10%
Profit Margin20.04%
P/E Ratio15.3
ROE12.56%
ROA0.59%
Debt/Equity44.28
P/B Ratio1.9
Op. Cash Flow$28.8B
Free Cash Flow$5.5B
Industry P/E16.8
Technical Analysis
TrendBullish
RSI51.2
Support$36.97
Resistance$40.41
MA 20$38.92
MA 50$37.11
MA 200$34.75
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value$74.65
Target Price$34.40
Upside/Downside-10.73%
GradeUndervalued
TypeBlend
Dividend Yield3.49%
Risk Assessment
Beta0.97
Volatility26.95%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.